Incidence of four major osteoporotic fragility fractures among older individuals in Sado, Japan, in 2020.

IF 2.4 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Journal of Bone and Mineral Metabolism Pub Date : 2024-11-01 Epub Date: 2024-07-08 DOI:10.1007/s00774-024-01529-z
Norio Imai, Asami Nozaki, Yugo Shobugawa, Kentaro Higuchi, Yoshihiro Suda, Takeo Oinuma, Hayato Suzuki, Yoji Horigome, Hiroyuki Kawashima
{"title":"Incidence of four major osteoporotic fragility fractures among older individuals in Sado, Japan, in 2020.","authors":"Norio Imai, Asami Nozaki, Yugo Shobugawa, Kentaro Higuchi, Yoshihiro Suda, Takeo Oinuma, Hayato Suzuki, Yoji Horigome, Hiroyuki Kawashima","doi":"10.1007/s00774-024-01529-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This study compared the 2020 incidence of fragility fractures in Sado City with those from 2004 to 2015.</p><p><strong>Materials and methods: </strong>Data from patients aged ≥ 60 years living in Sado City with fragility fractures in the hip, vertebral, distal radius, and proximal humerus between January 1 and December 31, 2020, were collected. We examined the number and incidence of four types of osteoporotic fractures in the older population aged ≥ 60 years living in Sado City in 2020. We compared the results with those of the 2004, 2010, and 2015 surveys, examining the temporal change and trend in the incidence of the four fracture types in this population. We investigated the use rate of anti-osteoporotic medications and the relationship between their administration and the occurrence of fragility fractures.</p><p><strong>Results: </strong>The age-specific incidence of hip fractures slightly decreased from 2015. However, the incidence of the other three fractures slightly increased, although the difference was not statistically significant. The incidence of hip fractures markedly increased in the 80 s. In 2020, the percentage of patients taking anti-osteoporotic agents before the occurrence of fractures decreased to 12.4% from 14.5% in 2015; it increased from 4% in 2004 to 7.6% in 2010.</p><p><strong>Conclusion: </strong>The 2020 incidence of the four fractures did not decrease, and the percentage of patients receiving anti-osteoporotic agents did not increase. A higher frequency of osteoporosis treatment is necessary to reduce the incidence of fragility fractures. We recommend using anti-osteoporotic agents to prevent hip fractures among individuals in their mid-70 s and above.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":"647-652"},"PeriodicalIF":2.4000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Bone and Mineral Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00774-024-01529-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/8 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: This study compared the 2020 incidence of fragility fractures in Sado City with those from 2004 to 2015.

Materials and methods: Data from patients aged ≥ 60 years living in Sado City with fragility fractures in the hip, vertebral, distal radius, and proximal humerus between January 1 and December 31, 2020, were collected. We examined the number and incidence of four types of osteoporotic fractures in the older population aged ≥ 60 years living in Sado City in 2020. We compared the results with those of the 2004, 2010, and 2015 surveys, examining the temporal change and trend in the incidence of the four fracture types in this population. We investigated the use rate of anti-osteoporotic medications and the relationship between their administration and the occurrence of fragility fractures.

Results: The age-specific incidence of hip fractures slightly decreased from 2015. However, the incidence of the other three fractures slightly increased, although the difference was not statistically significant. The incidence of hip fractures markedly increased in the 80 s. In 2020, the percentage of patients taking anti-osteoporotic agents before the occurrence of fractures decreased to 12.4% from 14.5% in 2015; it increased from 4% in 2004 to 7.6% in 2010.

Conclusion: The 2020 incidence of the four fractures did not decrease, and the percentage of patients receiving anti-osteoporotic agents did not increase. A higher frequency of osteoporosis treatment is necessary to reduce the incidence of fragility fractures. We recommend using anti-osteoporotic agents to prevent hip fractures among individuals in their mid-70 s and above.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2020 年日本佐渡地区老年人四种主要骨质疏松性脆性骨折的发病率。
简介本研究比较了佐渡市 2020 年与 2004 年至 2015 年的脆性骨折发生率:收集了 2020 年 1 月 1 日至 12 月 31 日期间佐渡市≥60 岁的髋部、脊椎、桡骨远端和肱骨近端脆性骨折患者的数据。我们调查了 2020 年佐渡市 60 岁以上老年人口中四种类型的骨质疏松性骨折的数量和发生率。我们将调查结果与 2004 年、2010 年和 2015 年的调查结果进行了比较,研究了该人群中四种骨折类型发病率的时间变化和趋势。我们还调查了抗骨质疏松药物的使用率以及用药与脆性骨折发生之间的关系:与2015年相比,髋部骨折的特定年龄发病率略有下降。然而,其他三种骨折的发生率略有上升,但差异无统计学意义。2020年,骨折发生前服用抗骨质疏松药物的患者比例从2015年的14.5%降至12.4%;从2004年的4%增至2010年的7.6%:结论:2020年四种骨折的发生率并未降低,接受抗骨质疏松药物治疗的患者比例也未增加。要降低脆性骨折的发生率,就必须提高骨质疏松症的治疗频率。我们建议 70 岁以上的中年人使用抗骨质疏松药物预防髋部骨折。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Bone and Mineral Metabolism
Journal of Bone and Mineral Metabolism 医学-内分泌学与代谢
CiteScore
6.30
自引率
3.00%
发文量
89
审稿时长
6-12 weeks
期刊介绍: The Journal of Bone and Mineral Metabolism (JBMM) provides an international forum for researchers and clinicians to present and discuss topics relevant to bone, teeth, and mineral metabolism, as well as joint and musculoskeletal disorders. The journal welcomes the submission of manuscripts from any country. Membership in the society is not a prerequisite for submission. Acceptance is based on the originality, significance, and validity of the material presented. The journal is aimed at researchers and clinicians dedicated to improvements in research, development, and patient-care in the fields of bone and mineral metabolism.
期刊最新文献
Osteoporosis screening using X-ray assessment and osteoporosis self-assessment tool for Asians in hip surgery patients. Responders and non-responders to romosozumab treatment. Multiple thyroid disorders and risk of osteoporosis: a two-sample Mendelian randomization study. Histological assessments for anabolic effects in teriparatide/abaloparatide administered rodent models. List of reviewers 2024.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1